-+ 0.00%
-+ 0.00%
-+ 0.00%

IMMUNOME - HAS NO FURTHER PAYMENT OBLIGATIONS TO BMS UNDER LICENSE AGREEMENT - SEC FILING

Reuters·10/05/2026 12:36:33